Following the successful Advanced Therapies Week in Dallas, our Chief Business Development Officer, Natalia Elizalde, contributed to a Drug Discovery World round-up that highlighted the most exciting topics and discussions from the event.
Her insights were featured under the subtitle “Evolving Landscape of CGT Manufacturing”, where she emphasized the increasing demand for high-quality lentiviral vectors, and the critical role of scalability and regulatory alignment in supporting global commercialization efforts within the cell and gene therapy (CGT) sector.
In addition, Natalia reflected on VIVEbiotech’s recognition as CMO/CDMO of the Year at the prestigious Advanced Therapies Awards. This recognition underscores the company’s continued commitment to delivering tailored, GMP-grade lentiviral vector solutions to meet the industry’s evolving needs.
Read the full round-up in Drug Discovery World here: https://www.ddw-online.com/hot-topics-news-and-discussions-at-advanced-therapies-week-2025-33581-202502/